Latest Epoxides Stories
Sales of the LABA/LAMA Combination Drug Class are Expected to Grow Significantly Over the Next Six Months, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug.
DALLAS, Aug. 19, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Deep Research Report on Global and China Epichlorohydrin Resin Industry" to its research database.
Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Kyprolis Helped Patients Live 8.7 Months Longer Without Their Disease Worsening THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Aug.
DUBLIN, June 24, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/h7kcsw/global_and)
Sterigenics International LLC, a global leader in outsourced contract sterilization services, today announced that it will invest more than $10 million to expand operations in Atlanta, Dallas
Each of the Emerging LABA/LAMA Fixed-Dose Combinations Has Advantages Over Current Therapies on Efficacy Measures, According to Findings from Decision Resources Group BURLINGTON, Mass., April
DUBLIN, April 22, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/22h3kv/epichlorohydrin) has announced the addition of the "Epichlorohydrin
DUBLIN, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qv9mlq/analysis_and) has announced the addition of the "Analysis
- A trick or prank.